This content is for informational purposes only and is not a substitute for professional advice.
Phenylpiracetam and piracetam require legal and medical screening before comparison, because regulatory categories decide whether a product should be bought at all.
Methodology
This comparison prioritizes lawful status, anti-doping risk, CNS side effects, product identity, and evidence limits for healthy adults.
| Criterion | Phenylpiracetam | Piracetam |
|---|---|---|
| Subjective profile | Often marketed as more stimulating | Often marketed as milder |
| Anti-doping | Prohibited in sport under WADA listings | Check rules and jurisdiction |
| U.S. supplement status | High legal concern | FDA warning letters have addressed piracetam claims |
| Trial risk | Insomnia, anxiety, stimulant-like effects | Headache, GI, medication concerns |
| Recommendation | Avoid casual use | Avoid casual use |
Decision criteria
Athletes should not use phenylpiracetam. People with psychiatric conditions, seizure history, cardiovascular symptoms, pregnancy, or CNS medication use should not self-test racetams. If cognitive symptoms are the reason for interest, seek evaluation rather than escalating compounds.
Sources
This article is educational and does not replace legal, anti-doping, or medical advice.
WADA. Prohibited List. https://www.wada-ama.org/en/prohibited-list
↩FDA warning letter discussing piracetam supplement claims. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cognitive-nutrition-llc-539376-02052018
↩FTC. Health Products Compliance Guidance. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
↩